Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway.
BMC Med Genet. 2010 Jul 15;11:112. doi: 10.1186/1471-2350-11-112.
Concerns about the general psychological impact of genetic testing have been raised. In the Environmental Triggers of Type 1 Diabetes (MIDIA) study, genetic testing was performed for HLA-conferred type 1 diabetes susceptibility among Norwegian newborns. The present study assessed whether mothers of children who test positively suffer from poorer mental health and well-being after receiving genetic risk information about their children.
The study was based on questionnaire data from the Norwegian Mother and Child Cohort (MoBa) study conducted by the Norwegian Institute of Public Health. Many of the mothers in the MoBa study also took part in the MIDIA study, in which their newborn children were tested for HLA-conferred genetic susceptibility for type 1 diabetes. We used MoBa questionnaire data from the 30th week of pregnancy (baseline) and 6 months post-partum (3-3.5 months after disclosure of test results). We measured maternal symptoms of anxiety and depression (SCL-8), maternal self-esteem (RSES), and satisfaction with life (SWLS). The mothers also reported whether they were seriously worried about their child 6 months post-partum. We compared questionnaire data from mothers who had received information about having a newborn with high genetic risk for type 1 diabetes (N = 166) with data from mothers who were informed that their baby did not have a high-risk genotype (N = 7224). The association between genetic risk information and maternal mental health was analysed using multiple linear regression analysis, controlling for baseline mental health scores.
Information on genetic risk in newborns was found to have no significant impact on maternal symptoms of anxiety and depression (p = 0.9), self-esteem (p = 0.2), satisfaction with life (p = 0.2), or serious worry about their child (OR = 0.98, 95% CI 0.64-1.48). Mental health before birth was strongly associated with mental health after birth. In addition, an increased risk of maternal worry was found if the mother herself had type 1 diabetes (OR = 2.39, 95% CI 1.2-4.78).
This study did not find evidence supporting the notion that genetic risk information about newborns has a negative impact on the mental health of Norwegian mothers.
人们对基因检测带来的普遍心理影响表示担忧。在环境触发 1 型糖尿病研究(MIDIA)中,对挪威新生儿进行了 HLA 易患 1 型糖尿病的基因检测。本研究评估了在获得有关子女遗传风险信息后,子女检测呈阳性的母亲的心理健康和幸福感是否会受到影响。
该研究基于挪威公共卫生研究所开展的挪威母亲和儿童队列研究(MoBa)的问卷调查数据。MoBa 研究中的许多母亲还参加了 MIDIA 研究,她们的新生儿接受了 HLA 易患 1 型糖尿病的基因易感性检测。我们使用 MoBa 研究在妊娠第 30 周(基线)和产后 6 个月(产后 3-3.5 个月)时的问卷调查数据。我们测量了母亲的焦虑和抑郁症状(SCL-8)、自尊(RSES)和生活满意度(SWLS)。母亲们还报告了她们在产后 6 个月时是否对孩子感到非常担忧。我们将收到有关新生儿具有 1 型糖尿病高遗传风险信息的母亲的问卷数据(N=166)与被告知婴儿没有高风险基因型的母亲的问卷数据(N=7224)进行了比较。使用多元线性回归分析,控制基线心理健康评分,分析遗传风险信息与母亲心理健康之间的关系。
研究结果表明,新生儿遗传风险信息对母亲的焦虑和抑郁症状(p=0.9)、自尊(p=0.2)、生活满意度(p=0.2)或对孩子的严重担忧(OR=0.98,95%CI 0.64-1.48)没有显著影响。出生前的心理健康与出生后的心理健康密切相关。此外,如果母亲本身患有 1 型糖尿病,则母亲担忧的风险增加(OR=2.39,95%CI 1.2-4.78)。
本研究没有证据表明新生儿遗传风险信息会对挪威母亲的心理健康产生负面影响。